INDV:NASDAQ
Indivior Pharmaceuticals Inc
$34.51
arrow_downward
-0.75%(-0.26) 1D
$34.51
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INDV...
Open
$34.58
High
$34.87
Low
$34.04
Mkt. cap
4.07B
Avg. vol.
2.34M
Volume
47.00
P/E ratio
12.42
52-wk high
$42.81
52-wk low
$22.22
EPS
$2.78
Beta
1.03
Shares outstanding
118.01M
No. of employees
833
Open
$34.58
High
$34.87
Low
$34.04
Mkt. cap
4.07B
Avg. vol.
2.34M
Volume
47.00
P/E ratio
12.42
52-wk high
$42.81
52-wk low
$22.22
EPS
$2.78
Beta
1.03
Shares outstanding
118.01M
No. of employees
833
News stories
From web sources and news partners
ad-hoc-news.de
·
19 hours ago
Indivior stock gains as Supernus merger and special dividend plan come into focus
Profile
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
About Indivior Pharmaceuticals Inc
CEOMark Crossley
Employees833
FoundedSep 26, 2014
Headquarters-
SectorPharmaceutical industry
Websiteindivior.com